LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,076,975 | -55.5% | 732,636 | -3.8% | 0.00% | -50.0% |
| Q2 2023 | $2,421,001 | +34.7% | 761,321 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,796,718 | -32.0% | 761,321 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,641,784 | -52.3% | 761,321 | +0.8% | 0.00% | -50.0% |
| Q3 2022 | $5,535,000 | +19.9% | 755,105 | +6.7% | 0.01% | +20.0% |
| Q2 2022 | $4,615,000 | +16.5% | 707,665 | -9.8% | 0.01% | +66.7% |
| Q1 2022 | $3,963,000 | -29.2% | 784,741 | +8.5% | 0.00% | 0.0% |
| Q4 2021 | $5,599,000 | -11.5% | 723,370 | +69.2% | 0.00% | 0.0% |
| Q3 2021 | $6,327,000 | +50.5% | 427,483 | +65.2% | 0.00% | +50.0% |
| Q2 2021 | $4,204,000 | – | 258,823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |